Patent · US Active

IL-31 dog pruritus model

US10526405B2 · kind B2 · utility

1Cited by
8References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 14, 2019
Grant dateJan 7, 2020
Priority date
Expiry dateAug 14, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An IL-31 dog pruritus model is provided. This model comprises administering canine IL-31 to dogs to produce a pruritic response; quantitatively measuring pruritic responses in the dogs which were administered canine IL-31; administering a candidate dog IL-31 inhibitor; and assessing the effectiveness of the candidate dog IL-31 inhibitor in reducing prurtic behavior in the treated dogs by challenging the dogs with canine IL-31 following the administration of the candidate dog IL-31 inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.